Sletten Cancer Inst Great Falls, MT - 59405

Sletten Cancer Inst is categorized under Noncommercial Research Organizations in Great Falls, MT and active since 2006.

Sletten Cancer Inst was established in 2006, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Noncommercial Research Organizations business, which does work in the B2B market, and is classified as a Noncommercial Research Organizations, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Joe Loduca, Administrator at the company’s single location by writing to 1117 29th St South # 200, Great Falls, Montana MT 59405 or by phoning (406) 731-8200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Sletten Cancer Inst
Contact Person: Joe Loduca, Administrator
Address: 1117 29th St South # 200, Great Falls, Montana 59405
Phone Number: (406) 731-8200
Website Address: benefis.org
Annual Revenue (USD): $10.000.000 to $19.9999.999
Founded: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Noncommercial Research Organizations
SIC Code: 8733
NAICS Code: 6211110
Share This Business:

Sletten Cancer Inst was started in 2006 to provide professional Noncommercial Research Organizations under the SIC code 8733 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.

Feel free to contact Joe Loduca, Administrator for inquiries that concern Sletten Cancer Inst by calling the company number (406) 731-8200, as your correspondence is most welcome. Additionally, the physical location of the single location of Sletten Cancer Inst can be found at the coordinates 47.49167,-111.25726 as well as the street address 1117 29th St South # 200 in Great Falls, Montana 59405.

For its online presence, you may visit Sletten Cancer Inst’s website at benefis.org and engage with its social media outlets through on Twitter and on Facebook.